Patent focus on antidiabetic agents: September 1999-February 2000

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 6, 2000, Pages 787-801

  Chu Moyer, M Y ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Antidiabetic agents; Diabetes; Hepatic glucose output inhibitors; Insulin secretagogues; Insulin sensitisers

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 6 [[2 [[2 (2 CYANO 1 PYRROLIDINYL) 2 OXOETHYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; CIGLITAZONE; CP 91149; DIPEPTIDYL PEPTIDASE IV; FARGLITAZAR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVATE DEHYDROGENASE; ROSIGLITAZONE; TROGLITAZONE; UNCLASSIFIED DRUG; VALINE THIAZOLIDIDE;

DIABETES MELLITUS; DRUG RESEARCH; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HUMAN; INSULIN RELEASE; LIVER METABOLISM; MOUSE; NONHUMAN; RAT; REVIEW;

EID: 0034116527     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.6.787     Document Type: Review

References (72)